asthma - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

New asthma drug approved on NHS branded a ‘wonder drug’

NICE has issued a Final Appraisal Determination (FAD) recommending dupilumab as an add-on maintenance treatment for severe asthma. Dupilumab (also known as Dupixe...

20 October 2021 News asthma | drug

Continue Reading →

Volume 13 Issue 3

Smart Inhalers: A Digital Step Towards Patient-Centricity

Respiratory infections continue to have the highest incidence rate in Europe. Where asthma is considered, there has been a sharp increase in global cases, morbidity,...

13 September 2021 Volume 13 Issue 3 asthma | H&T Presspart

Continue Reading →

Volume 13 Issue 3

New DPI Data Insights Shaping Future of Global Healthcare Needs

Innovative inhalation therapies and drug delivery are legacies of the COVID-19 pandemic, as pharma and biopharma formulators address growing demands for new healthca...